SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages
Zhenfeng Wang(Henan University), Bo Huang(Guangdong Pharmaceutical University), Qiangqiang Zhu(Yunnan Agricultural University), Ran Gao(National Institute of Advanced Industrial Science and Technology), Jiangping Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Yabo Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Deng(Wuhan Institute of Virology), Chuan Qin(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiadi Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Yajin Qu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuying Liu(Tianjin University of Science and Technology), Pin Yü(Chinese Academy of Medical Sciences & Peking Union Medical College), Shunshun Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei‐Min Tong(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiangning Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Zhou(North Sichuan Medical University)
Cited by 32
Related Papers
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
|Molecular Cell|2012|3.7k
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
|Viruses|2019|1.3k